Mohammad A Kamal
Overview
Explore the profile of Mohammad A Kamal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
219
Citations
2212
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mallari P, Taulier T, Kamal M
Cureus
. 2024 Dec;
16(12):e76279.
PMID: 39726863
This case report explores the journey to a healthier life of a 57-year-old man who stayed athletic after contracting COVID-19 during a trip to a foreign country. He had minimal...
2.
Saleh O, Albakri K, Altiti A, Abutair I, Shalan S, Mohd O, et al.
CNS Neurol Disord Drug Targets
. 2023 May;
23(6):731-745.
PMID: 37211844
Long non-coding RNAs (IncRNAs) are regulatory RNA transcripts that have recently been associated with the onset of many neurodegenerative illnesses, including Alzheimer's disease (AD). Several IncRNAs have been found to...
3.
Abdelkhalek A, Attia M, Kamal M
Curr Med Chem
. 2023 Feb;
31(14):1896-1919.
PMID: 36852819
Molecules containing triazolopyrimidine core showed diverse biological activities, including anti-Alzheimer's, anti-diabetes, anti-cancer, anti-microbial, anti-tuberculosis, anti-viral, anti-malarial, anti-inflammatory, anti-parkinsonism, and anti-glaucoma activities. Triazolopyrimidines have 8 isomeric structures, including the most stable...
4.
Reale M, Costantini E, Aielli L, Di Giuseppe F, Angelucci S, Kamal M, et al.
Int J Mol Sci
. 2022 Dec;
23(23).
PMID: 36499421
Aging is a complex process often accompanied by cognitive decline that represents a risk factor for many neurodegenerative disorders including Alzheimer's and Parkinson's disease. The molecular mechanisms involved in age-related...
5.
Khalid A, Haseeb A, Mushtaq G, Kamal M
EXCLI J
. 2022 Dec;
21:1304-1305.
PMID: 36483913
No abstract available.
6.
Pauly I, Singh A, Kumar A, Singh Y, Thareja S, Kamal M, et al.
Curr Pharm Des
. 2022 Nov;
28(46):3677-3705.
PMID: 36345244
Material And Methods: Docking studies were performed using the Maestro 12.9 module of Schrodinger software over 70 molecules with RdRp as the target and remdesivir as the standard drug and...
7.
Bajrai L, Sohrab S, Khalid M, Kamal M, Azhar E
Cell Mol Biol (Noisy-le-grand)
. 2022 Oct;
68(6):31-35.
PMID: 36227681
It has been seen that, during COVID-19 outbreak lung cancer (LC) patients are noted as a high-risk population which make a more challenging to treatment of the LC patients. The...
8.
Louka A, Tsagkaris C, Christoforou P, Khan A, Alexiou F, Simou P, et al.
Front Biosci (Landmark Ed)
. 2022 Aug;
27(8):232.
PMID: 36042184
While frailty corresponds to a multisystem failure, geriatric assessment can recognize multiple pathophysiological lesions and age changes. Up to now, a few frailty indexes have been introduced, presenting definitions of...
9.
Chopra H, Baig A, Gautam R, Kamal M
Curr Pharm Des
. 2022 Jun;
28(33):2690-2703.
PMID: 35676841
Due to the heap of data sets available for drug discovery, modern drug discovery has taken the shape of big data. Usage of Artificial intelligence (AI) can help to modify...
10.
Unnisa A, Greig N, Kamal M
Curr Med Chem
. 2022 Mar;
30(3):255-270.
PMID: 35345990
Nanotechnology is the process of modulating shape and size at the nanoscale to design and manufacture structures, devices, and systems. Nanotechnology's prospective breakthroughs are incredible, and some cannot even be...